Unexplained Anemia in the Elderly: Potential Role of Arterial Stiffness by David Montero et al.
OPINION
published: 25 October 2016
doi: 10.3389/fphys.2016.00485
Frontiers in Physiology | www.frontiersin.org 1 October 2016 | Volume 7 | Article 485
Edited by:
Kari Kalliokoski,
University of Turku, Finland
Reviewed by:
Dietmar Fuchs,
Innsbruck Medical University, Austria
*Correspondence:
David Montero
david.montero.barril@gmail.com
Specialty section:
This article was submitted to
Clinical and Translational Physiology,
a section of the journal
Frontiers in Physiology
Received: 06 September 2016
Accepted: 10 October 2016
Published: 25 October 2016
Citation:
Montero D, Diaz-Cañestro C,
Flammer A and Lundby C (2016)
Unexplained Anemia in the Elderly:
Potential Role of Arterial Stiffness.
Front. Physiol. 7:485.
doi: 10.3389/fphys.2016.00485
Unexplained Anemia in the Elderly:
Potential Role of Arterial Stiffness
David Montero 1*, Candela Diaz-Cañestro 2, Andreas Flammer 1 and Carsten Lundby 3
1Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland, 2Center for Molecular
Cardiology, University of Zurich, Zurich, Switzerland, 3 Zurich Center for Integrative Human Physiology, Institute of Physiology,
University of Zurich, Zurich, Switzerland
Keywords: arterial stiffness, erythropoietin, blood volume, anemia
INTRODUCTION
Anemia, as defined by hemoglobin concentration <12.0 and <13.0 g/dl in women and men,
respectively, affects more than 150 million elderly people worldwide and even when mild is
associated with increased disability, morbidity, and mortality (Ezekowitz et al., 2003; Penninx
et al., 2004; De Benoist et al., 2008). The causes of anemia remain unresolved in approximately
one-third of anemic older individuals, commonly referred as unexplained anemia in the elderly
(UAE; Guralnik et al., 2004). As most types of anemia, UAE is normocytic and its prevalence
increases with advancing age (Guralnik et al., 2004). UAE is uniquely characterized by low plasma
erythropoietin (EPO) concentration compared to the other forms of anemia (Ferrucci et al., 2007;
Artz and Thirman, 2011). Thus, provided that EPO is mainly synthesized in the kidneys and its
clearance/degradation is not enhanced, UAEmay be primarily determined by factors affecting renal
EPO production and/or hemodilution (Lundby et al., 2014; de Seigneux et al., 2016). These factors
are yet to be elucidated. Of note, while hemoglobin concentration is typically employed to diagnose
anemia, true (non-hemodilutional) anemia is defined as a decrease in the total volume of red blood
cells (RBCV) and/or hemoglobin mass. Herein, we present arguments to support the contention
that a fundamental hallmark of vascular aging, arterial stiffness (AS), might be a primary etiological
determinant of low EPO concentration and RBCV in UAE via the impairment of mechanisms
regulating kidney perfusion, EPO production as well as blood volume. This viewpoint postulates
that AS is augmented in UAE patients compared with healthy non-anemic elderly individuals.
While direct proof is not available at present, independent lines of evidence demonstrate that
UAE is characterized by alterations in biochemical, hematological, and physiological parameters
consistently associatedwith AS (Ferrucci et al., 2007; Robinson et al., 2007; Artz et al., 2014;Malahfji
et al., 2014), whereof some are described in detail below.
ASSOCIATION BETWEEN ARTERIAL STIFFNESS (AS) AND THE
TOTAL VOLUME OF RED BLOOD CELLS (RBCV)
AS characterizes the reduced capacity of an artery to expand and recoil in response to changes
in blood pressure. When assessed in central elastic arteries (e.g., carotid), AS independently
predicts incident cardiovascular events, kidney disease, and all-cause mortality (Hashimoto and
Ito, 2011; van Sloten et al., 2014). Sedentary aging is inexorably associated with a linear or
exponential increase in AS (Avolio et al., 1983; Mitchell et al., 2004; McEniery et al., 2005),
possibly reflecting the gradual fragmentation of elastin fibers due to repetitive cyclic stress as
well as the simultaneous accumulation of collagen fibers in the media layer of elastic arteries
(O’Rourke and Hashimoto, 2007; Camici et al., 2015). Nonetheless, there is substantial variability
in the degree of arterial stiffening with advancing age (Avolio et al., 1983). For instance, older
individuals regularly involved in endurance training may present similar low levels of AS than
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healthy young controls (Vaitkevicius et al., 1993; Tanaka et al.,
1998). These elderly endurance-trained individuals also exhibit
a preserved blood volume and RBCV, both declining with
age in sedentary adults (Jones et al., 1997). The increase in
RBCV commonly observed with endurance training in healthy
individuals has been proposed to be partially related to frequent
reductions in central (intrathoracic) venous pressure (CVP)
stimulating EPO synthesis after each exercise bout (Kirsch
et al., 2005; Montero et al., 2015), in line with the basal
(non-hypoxic) regulation of EPO production as outlined in the
next section. Parenthetically, RBCV is the main determinant
of cardiorespiratory capacity (Montero et al., 2015), which in
turn is inversely associated with AS irrespective of age status
(Vaitkevicius et al., 1993; Ferreira et al., 2003; Kitzman et al.,
2013). Thus, it is reasonable to expect a negative relationship
between AS and RBCV, and this has been recently confirmed
experimentally (Montero et al., 2016a). Specifically, carotid AS
and carotid-ankle pulse wave velocity are strongly and negatively
associated (r ≥ −0.62) with total hemoglobin mass, RBCV,
and blood volume independently of body weight and gender in
healthy adults (Montero et al., 2016a). In addition, augmentation
index, an indirect measure of AS, has been negatively related
to blood hemoglobin concentration in a cohort of individuals
presenting with diabetes alone or along with anemia (Demir et al.,
2015). It should be noted, however, that statistical associations
do not necessarily infer strict causal relationships. Both AS
and impaired erythropoiesis could be caused by a common
underlying process, e.g., an age-related increase in circulating
pro-inflammatory cytokines (Makipour et al., 2008; Artz et al.,
2014), which may hinder proliferation and differentiation of
erythroid progenitor cells independently of circulating EPO
levels (Means, 1995; Selleri et al., 1996). Acknowledging this
uncertainty, multiple linear correlative evidence impelled us to
ponder whether AS-related mechanisms may adversely influence
the regulation of erythropoiesis and explain, at least in part, the
uncertain pathophysiology of UAE.
REGULATION OF ERYTHROPOIETIN (EPO)
SYNTHESIS THROUGH BLOOD VOLUME
FEEDBACK MECHANISMS
It is beyond dispute that tissue hypoxia in peritubular fibroblast-
like cells of the renal cortex stimulates the synthesis of EPO upon
stabilization of hypoxia-inducible factor-2α (Jelkmann, 2011).
However, additional non-hypoxic feedback mechanisms must
also regulate EPO production since arterial O2 partial pressure
and renal blood flow/O2 consumption seldom fluctuate to values
required to substantially increase the synthesis of EPO in healthy
individuals (Halperin et al., 2006; Perez-Padilla et al., 2006).
Among potential non-hypoxic factors related to erythropoiesis,
EPO concentrations run inversely to CVP, a variable reflecting
the filling state of the cardiovascular system (Ehmke et al., 1995;
Gunga et al., 1996; Breymann et al., 2000). In this respect, early
animal studies observed a 1.5-fold acute increase in plasma
EPO levels following a reduction of blood volume (20%) and
CVP while hematocrit was unaltered (Ehmke et al., 1995). In
humans, hypervolemic hemodilution increasing CVP paralleled a
decrease in circulating EPO seemingly beyond the dilution effect
(Breymann et al., 2000). Recently, plasma EPO concentration
was found increased independent of hemoconcentration, with
moderate head-up tilt redistributing blood toward the lower
limbs and thereby reducing CVP (Montero et al., 2016b). Overall,
these studies suggest that CVP per-se could be a regulator of EPO
production.
The specific mechanism(s) explaining the link between CVP
and EPO synthesis has yet to be established. Nonetheless, changes
in EPO concentration in response to variations in CVP resembles
the pattern of hormones governing blood volume such as those
pertaining to the renin-angiotensin-aldosterone system (RAAS)
as well as natriuretic peptides and vasopressin (VPN; Gauer and
Henry, 1963). These hormones regulate blood volume through
feedback loops including veno-atrial and arterial baroreceptors
(Gauer and Henry, 1963). Interestingly, angiotensin II (ANGII)
and VPN stimulate EPO synthesis in vivo independently of
kidney tissue hypoxia (Engel and Pagel, 1995; Kim et al., 2014),
and are augmented when CVP is decreased (Segar and Moore,
1968; Egan et al., 1984; Bie et al., 1986; Sander-Jensen et al.,
1986). Accordingly, the production of EPO has been proposed
to be regulated under basal (non-kidney hypoxic) conditions by
blood volume-regulating hormones (Kirsch et al., 2005). Hence,
EPO synthesis and therefore erythropoiesis could be affected by
alterations in hemodynamic and endocrine feedback pathways
that control blood volume.
POTENTIAL MECHANISMS LINKING
ARTERIAL STIFFNESS (AS) AND LOW
ERYTHROPOIETIN (EPO)
CONCENTRATION IN UNEXPLAINED
ANEMIA IN THE ELDERLY (UAE)
(FIGURE 1)
Altered Baroreflex Sensitivity (BRS) and
Stimulated Release of Blood
Volume-Regulating Hormones
Baroreflex sensitivity (BRS) declines progressively with age
and is primarily associated with the compliance of central
elastic arteries in which high-pressure baroreceptors are located
(aortic arch and carotid arteries; Monahan et al., 2001a).
This is only natural given that baroreceptor firing rate is
proportional to changes in arterial circumference (Kingwell et al.,
1995). Monahan et al. demonstrated that carotid compliance
independently explains the majority of the variance of BRS
across the lifespan (Monahan et al., 2001a). Moreover, age-
related reduction in BRS is largely attenuated by endurance
training (Monahan et al., 2000, 2001a,b), which concurs with the
aforementioned observations regarding AS and hematological
variables. Taking into account that arterial baroreceptors control
the secretion of blood volume-regulating hormones such as
VPN (Thrasher, 1994; Thrasher and Keil, 1998), this could be
affected by AS. In this regard, increased arterial pulse pressure,
a common correlate of AS and impaired BRS (Virtanen et al.,
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FIGURE 1 | Central hypothesis linking arterial stiffness in central elastic arteries and low EPO concentration in UAE. EPCs, epo-producing cells; EPO,
erythropoietin; UAE, unexplained anemia in the elderly.
2004), decreases the release of VPN even in the absence of
changes in mean arterial pressure (Gabrielsen et al., 2000). In
this line, aging has been associated with a blunted VPN release
in response to conditions associated with reduced CVP such
as acute post-exercise hypotension (Kirsch et al., 1986; Halliwill
et al., 2000; Keck et al., 2000). Importantly, the increase in EPO
concentration induced by decreasing CVP is abolished when
adjusted for the concomitant increase in copeptin (Montero et al.,
2016b), a marker of VPN (Morgenthaler et al., 2008). Indeed,
changes in copeptin with experimental manipulation of CVP
independently explained simultaneously occurring changes in
EPO concentration in healthy adults (Montero et al., 2016b).
Furthermore, VPN administration is associated with increased
plasma EPO levels and red cell mass in hypopituitaric patients
(Jepson et al., 1968). As for the underlying mechanisms, animal
studies demonstrated that VPN directly induces EPO secretion
through the activation of V1a receptors (Engel and Pagel, 1995),
which are expressed in the renal cortex and medulla and mediate
the vasopressor effect of VPN (Gózdz et al., 2002; Koshimizu
et al., 2006). Therefore, whilst speculative, the characteristic low
EPO concentration in UAE could be attributed, at least in part,
to reduced VPN release secondary to AS and impaired BRS. The
rate of VPN delivery to kidney target cells depends, in addition to
plasma VPN concentration and plasma volume, on renal blood
flow, which leads us to the next potential mechanisms linking AS
and UAE.
Altered Renal Blood Flow
The relationship between AS and kidney function is amply
acknowledged in the literature (Safar et al., 2004; O’Rourke
and Safar, 2005; Ford et al., 2010). Central to this relationship
is the inherent loss of the elastic recoil (Windkessel function)
in the descending aorta, which supplies blood to the kidneys.
The higher the degree of aortic stiffening, the greater is the
aortic upstream (reverse) flow in early diastole (Hashimoto and
Ito, 2013). Kidney perfusion and thereby glomerular filtration
rate (GFR) are reduced according to the increase in aortic
flow reversal, independent of cardiac output (Hashimoto and
Ito, 2015). In fact, the aortic reverse/forward flow ratio is
the strongest determinant of estimated GFR as well as renal
blood flow, and mediates the association of AS with GFR in
hypertensive patients (Hashimoto and Ito, 2015). In individuals
with UAE, a low estimated GFR (≤ 60mL·min·1.73 m2)
seems prevalent (Robinson et al., 2007; Artz et al., 2014),
possibly reflecting a concomitant reduction in renal blood flow
considering its expected association with GFR (Lebkowska et al.,
2007; Hashimoto and Ito, 2015). Consequently, AS may lead to
a specific reduction of blood flow to the kidneys, thus diminish
the delivery of blood-volume regulating hormones and as a direct
consequence hereof affect EPO synthesis.
Impaired Tissue Perfusion
One of the most clinically relevant outcomes derived from AS
is the increase in blood pressure pulse amplitude (Struijker-
Boudier, 2009). The augmented pulsatility primarily impacts on
the smallest arteries and arterioles, i.e., the resistance vasculature.
When the increase in pulse pressure is maintained, adverse
phenotypic changes are commonly observed, particularly in
vascular beds characterized by low resistance such as the renal
microcirculation (Mitchell, 2008; Woodard et al., 2015). These
microvascular alterations include increased media-to-lumen
ratio, decreased arteriolar diameter, and capillary rarefaction,
among others (Levy et al., 2001). In this respect, an increased
vascular resistance and reduced arterial volume in the renal
cortex explain the negative association between renal artery
pulsatility index (PI) and GFR in older adults (Woodard et al.,
2015). Furthermore, the association between AS, pulse pressure
andmicrovascular abnormalities is not a one-way relationship, in
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that the latter may contribute to AS and pulse pressure, leading
to a vicious circle (Struijker-Boudier, 2009). Not surprisingly,
impaired tissue perfusion is common to diseases characterized
by AS such as hypertension, obesity, diabetes mellitus, and aging
per-se (Delp et al., 1998; Levy et al., 2008). Hence, AS could
cause a specific reduction in the microvascular perfusion of
peritubular fibroblast-like cells of the renal cortex (i.e., kidney
EPO-producing cells; Jelkmann, 2011), thus being another
contributing factor to low EPO concentration in UAE.
CONCLUSION
Among all types of anemia, the most prevalent, UAE, remain
currently unexplained (Artz and Thirman, 2011). In this
viewpoint, we have highlighted the plausibly overlooked role of
AS, a well-known feature of the vascular aging process, as a
primary contributing factor to the typical low EPO concentration
observed in UAE. Underlying mechanisms are proposed
to include the impairment of endocrine feedback pathways
governing the basal regulation of kidney EPO synthesis as well
as renal perfusion. In particular, AS in central elastic arteries
leading to baroreceptor dysfunction may hinder the release of
blood volume-regulating hormones directly stimulating EPO
synthesis. Moreover, AS is closely linked with the reduction of
renal blood flow and microvascular perfusion contributing to
impaired hormone delivery to EPO-producing cells. While the
rationale underlying the potential impact of AS on the etiology
of UAE is based on fundamental hemodynamic and endocrine
(dys) regulation, its specific relevance to UAE will have to be
established in future studies. These may yield relevant insights
for novel and effective therapeutic targets in the treatment
of UAE.
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